NCT00484679View on ClinicalTrials.gov

Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

March 31, 2011

Conditions
Alopecia Areata
Interventions
DRUG

Triamcinolone Acetonide 10 mg/mL (Kenalog-10)

Triamcinolone Acetonide 10 mg/ml (Kenalog-10) intralesional injection

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
collaborator

National Alopecia Areata Foundation

OTHER

lead

University of Minnesota

OTHER

NCT00484679 - Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata | Biotech Hunter | Biotech Hunter